Update on clinical options for the management of allergic rhinitis

Mohsen Nasir, J. Andrew Grant

Research output: Contribution to journalArticle

Abstract

Allergic rhinitis is a common, chronic medical condition affecting millions of people worldwide. Uncontrolled disease has been associated with impairments in quality of life and decreased economic productivity. Proper identification and control of relevant co- morbid conditions is essential for optimal rhinitis control. Management of allergic rhinitis includes identification of relevant allergens, education on avoidance measures, medications and immunotherapy. First-line therapy includes the use on an intranasal steroid. Other treatment options include oral or intranasal antihistamines, decongestants, leukotriene receptor antagonists, mast cell stabilizers or anticholinergic agents. Immunotherapy is an effective treatment option for refractory disease.

Original languageEnglish (US)
Pages (from-to)379-394
Number of pages16
JournalClinical Medicine Insights: Therapeutics
Volume3
DOIs
StatePublished - 2011

Fingerprint

Immunotherapy
Nasal Decongestants
Leukotriene Antagonists
Histamine Antagonists
Cholinergic Antagonists
Rhinitis
Mast Cells
Allergens
Therapeutics
Steroids
Economics
Quality of Life
Education
Allergic Rhinitis

Keywords

  • Allergic rhinitis
  • Antihistamines
  • Avoidance measures
  • Immunotherapy
  • Intranasal steroids

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology
  • Medicine(all)

Cite this

Update on clinical options for the management of allergic rhinitis. / Nasir, Mohsen; Andrew Grant, J.

In: Clinical Medicine Insights: Therapeutics, Vol. 3, 2011, p. 379-394.

Research output: Contribution to journalArticle

@article{ef7fefdceadb46cdb03e34a19eb2da35,
title = "Update on clinical options for the management of allergic rhinitis",
abstract = "Allergic rhinitis is a common, chronic medical condition affecting millions of people worldwide. Uncontrolled disease has been associated with impairments in quality of life and decreased economic productivity. Proper identification and control of relevant co- morbid conditions is essential for optimal rhinitis control. Management of allergic rhinitis includes identification of relevant allergens, education on avoidance measures, medications and immunotherapy. First-line therapy includes the use on an intranasal steroid. Other treatment options include oral or intranasal antihistamines, decongestants, leukotriene receptor antagonists, mast cell stabilizers or anticholinergic agents. Immunotherapy is an effective treatment option for refractory disease.",
keywords = "Allergic rhinitis, Antihistamines, Avoidance measures, Immunotherapy, Intranasal steroids",
author = "Mohsen Nasir and {Andrew Grant}, J.",
year = "2011",
doi = "10.4137/CMT.S6375",
language = "English (US)",
volume = "3",
pages = "379--394",
journal = "Clinical Medicine Insights: Therapeutics",
issn = "1179-559X",
publisher = "Libertas Academica Ltd.",

}

TY - JOUR

T1 - Update on clinical options for the management of allergic rhinitis

AU - Nasir, Mohsen

AU - Andrew Grant, J.

PY - 2011

Y1 - 2011

N2 - Allergic rhinitis is a common, chronic medical condition affecting millions of people worldwide. Uncontrolled disease has been associated with impairments in quality of life and decreased economic productivity. Proper identification and control of relevant co- morbid conditions is essential for optimal rhinitis control. Management of allergic rhinitis includes identification of relevant allergens, education on avoidance measures, medications and immunotherapy. First-line therapy includes the use on an intranasal steroid. Other treatment options include oral or intranasal antihistamines, decongestants, leukotriene receptor antagonists, mast cell stabilizers or anticholinergic agents. Immunotherapy is an effective treatment option for refractory disease.

AB - Allergic rhinitis is a common, chronic medical condition affecting millions of people worldwide. Uncontrolled disease has been associated with impairments in quality of life and decreased economic productivity. Proper identification and control of relevant co- morbid conditions is essential for optimal rhinitis control. Management of allergic rhinitis includes identification of relevant allergens, education on avoidance measures, medications and immunotherapy. First-line therapy includes the use on an intranasal steroid. Other treatment options include oral or intranasal antihistamines, decongestants, leukotriene receptor antagonists, mast cell stabilizers or anticholinergic agents. Immunotherapy is an effective treatment option for refractory disease.

KW - Allergic rhinitis

KW - Antihistamines

KW - Avoidance measures

KW - Immunotherapy

KW - Intranasal steroids

UR - http://www.scopus.com/inward/record.url?scp=80053600144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053600144&partnerID=8YFLogxK

U2 - 10.4137/CMT.S6375

DO - 10.4137/CMT.S6375

M3 - Article

VL - 3

SP - 379

EP - 394

JO - Clinical Medicine Insights: Therapeutics

JF - Clinical Medicine Insights: Therapeutics

SN - 1179-559X

ER -